Compare LNTH & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | PFSI |
|---|---|---|
| Founded | 1956 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.7B |
| IPO Year | 2014 | 2018 |
| Metric | LNTH | PFSI |
|---|---|---|
| Price | $95.42 | $88.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $87.00 | ★ $128.11 |
| AVG Volume (30 Days) | ★ 765.0K | 477.8K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | ★ 1.80 | 1.53 |
| Revenue | $343,374,000.00 | ★ $984,629,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.19 | $16.96 |
| P/E Ratio | ★ $53.29 | $57.92 |
| Revenue Growth | ★ 3.62 | 3.05 |
| 52 Week Low | $47.27 | $82.65 |
| 52 Week High | $95.98 | $160.36 |
| Indicator | LNTH | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 75.76 | 46.17 |
| Support Level | $72.35 | $88.63 |
| Resistance Level | N/A | $95.79 |
| Average True Range (ATR) | 2.94 | 2.26 |
| MACD | 0.96 | -0.19 |
| Stochastic Oscillator | 96.97 | 46.75 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.